Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?

Metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulators (NAMs) may play a role in some psychiatric disorders such as anxiety and depression. The pharmacokinetic profile and pharmacodynamics effects of mGluR5-NAMs have been previously reported. We performed a post hoc analysis of ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou Farha, Khalid, Bruggeman, Richard, Baljé-Volkers, Corine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960763/
https://www.ncbi.nlm.nih.gov/pubmed/24729909
http://dx.doi.org/10.1155/2014/652750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960763/
https://www.ncbi.nlm.nih.gov/pubmed/24729909
http://dx.doi.org/10.1155/2014/652750

Ejemplares similares